Market Overview:
The global Vibrio parahaemolyticus nucleic acid detection kit market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of Vibrio parahaemolyticus infections, rising demand for rapid and accurate diagnosis of Vibrio parahaemolyticus infections, and technological advancements in nucleic acid detection kits. Based on type, the global Vibrio parahaemolyticus nucleic acid detection kit market can be segmented into dry PCR and fluorescence PCR. The fluorescence PCR segment is expected to grow at a higher CAGR than the dry PCR segment during the forecast period from 2018 to 2030. This growth can be attributed to the advantages offered by fluorescence PCR over dry PCR such as high sensitivity and specificity, ability to detect low levels of DNA or RNA present in samples, and shorter turnaround time for results. Based on application, the global Vibrio parahaemolyticus nucleic acid detection kit market can be divided into hospital laboratories and clinic laboratories.
Product Definition:
The Vibrio parahaemolyticus Nucleic Acid Detection Kit is a diagnostic tool used to detect the presence of the Vibrio parahaemolyticus bacteria in food and environmental samples. The kit uses a polymerase chain reaction (PCR) assay to amplify and detect specific DNA sequences from the Vibrio parahaemolyticus bacterium. The kit is important for detecting this bacterium in food and environmental samples, as it can cause serious illness in humans.
Dry PCR:
Dry PCR, also known as liquid-based PCR (L-PCR) is a new and innovative technique that uses DNA extracted from the sample to detect the presence of nucleic acid. This method eliminates any risk of contamination during sample preparation and downstream detection. The technology has been used to successfully detect SARS-CoV-2 in clinical samples with high sensitivity & specificity.
Fluorescence PCR:
Fluorescence Polymerase Chain Reaction (PCR) is a technique that uses fluorescent dyes to copy and amplify the DNA sequence. The process is widely used in molecular diagnostics for the detection of infectious diseases such as HIV, hepatitis B & C, and cervical cancer. Fluorescence PCR also allows quantification of real-time during amplification along with providing information about the efficiency of each cycle. This technology has been applied to bacterial pathogens such as Salmonella spp.
Application Insights:
The global market is segmented by application into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a high prevalence of V. parahaemolyticus-related infections and rising number of research initiatives for its diagnosis across the globe. Increasing investments by governments for the development of diagnostic kits specific to Vibrio species are also expected to drive demand over the forecast period. For instance, according to an article published by NCBI in 2018, researchers from CDC developed a rapid test that can be performed within 20 minutes using wet laboratory techniques such as culture or detection blood tests on request from patients with diarrhea at any stage during its progression (early acute phase).
Regional Analysis:
North America dominated the global market in 2017. The presence of advanced healthcare infrastructure, high disposable income, and increasing awareness about early diagnosis are some of the major factors responsible for this dominance. Moreover, rising incidence of seafood-borne illnesses has led to increased demand for these tests in this region. According to a study published by CDC in 2016, there were approximately 3 million cases of Vibrio infections reported from U.S.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to continuous investments by governments & private sector companies towards R&D activities relatedto infectious diseases including vibriosis is contributing towards this growth.
Growth Factors:
- Increasing demand for rapid and accurate diagnosis of Vibrio parahaemolyticus infections from hospitals, diagnostic laboratories, and food testing laboratories
- Growing awareness about the benefits of using nucleic acid detection kits for diagnosing Vibrio parahaemolyticus infections
- Technological advancements in nucleic acid detection kits that offer enhanced performance and accuracy
- Rising number of outbreaks of Vibrio parahaemolyticus infections across the world
- increasing funding for research on nucleic acid detection kits for diagnosing Vibrio parahaemolyticus infections
Scope Of The Report
Report Attributes
Report Details
Report Title
Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market Research Report
By Type
Dry PCR, Fluorescence PCR
By Application
Hospital, Clinic
By Companies
BioGerm, Liferiver, Mole, Bioperfectus, Kinghawk, HFBiotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market Report Segments:
The global Vibrio Parahaemolyticus Nucleic Acid Detection Kit market is segmented on the basis of:
Types
Dry PCR, Fluorescence PCR
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioGerm
- Liferiver
- Mole
- Bioperfectus
- Kinghawk
- HFBiotech
Highlights of The Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry PCR
- Fluorescence PCR
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Vibrio Parahaemolyticus Nucleic Acid Detection Kit is a diagnostic tool used to detect the presence of nucleic acid in samples.
Some of the key players operating in the vibrio parahaemolyticus nucleic acid detection kit market are BioGerm, Liferiver, Mole, Bioperfectus, Kinghawk, HFBiotech.
The vibrio parahaemolyticus nucleic acid detection kit market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market Size & Forecast, 2020-2028
4.5.1 Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market Size and Y-o-Y Growth
4.5.2 Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Dry PCR
5.2.2 Fluorescence PCR
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Dry PCR
9.6.2 Fluorescence PCR
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Dry PCR
10.6.2 Fluorescence PCR
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Dry PCR
11.6.2 Fluorescence PCR
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Dry PCR
12.6.2 Fluorescence PCR
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Dry PCR
13.6.2 Fluorescence PCR
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market: Competitive Dashboard
14.2 Global Vibrio Parahaemolyticus Nucleic Acid Detection Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BioGerm
14.3.2 Liferiver
14.3.3 Mole
14.3.4 Bioperfectus
14.3.5 Kinghawk
14.3.6 HFBiotech
